PhD in Oncology, Chief Physician, Professor, and Doctoral Supervisor; Director of the Department of Supportive Care and Daytime Chemotherapy Ward; Head of the Internal Medicine Division of the Head and Neck Tumor Multidisciplinary Team (MDT) at Beijing Cancer Hospital. Expert entitled to Special Government Allowance from the State Council, National Candidate for the "New Century Hundred, Thousand, Ten Thousand Talents Project," Person in Charge of the "Mission Talent" Program and Humanistic Department of the Beijing Municipal Hospital Authority, and Director of the MASCC Center of Excellence. **Professional Expertise:** Provides diagnostic consultation, treatment plan analysis, and therapeutic decision-making support for cancer patients; delivers palliative internal medicine treatments; advocates for multidisciplinary team (MDT) consultations and customizes comprehensive disease management plans. Pioneers the "Supportive Care Meets Daytime" model, establishing a multidisciplinary supportive care team encompassing medicine, nursing, pharmacy, and nutrition to offer individualized comprehensive treatment plans for patients and their families, while conducting related research. **Major Social Affiliations:** Executive Director and Deputy Secretary-General, China Anti-Cancer Association Standing Committee Member, Committee of Oncology Internal Medicine, China Anti-Cancer Association Standing Committee Member, Committee of Cancer Supportive Care, China Anti-Cancer Association Founding Chair, Tumor Palliative Care and Humanistic Care Branch (later renamed Tumor Palliative Medicine Branch), China International Exchange and Promotive Association for Medical and Health Care Standing Committee Member, Committee of Cancer Rehabilitation and Palliative Care, China Anti-Cancer Association **Representative Achievements:** [1] Editorial Board Member, *Chinese Expert Consensus on Prevention and Treatment of Delayed Nausea and Vomiting (2022 Edition)*, Committee of Cancer Supportive Care, China Anti-Cancer Association [2] Deputy Editor-in-Chief, *Clinical Practice Guidelines for Cancer-Related Fatigue in China (2021 Edition)*, Group of Cancer Supportive and Rehabilitative Therapy, Oncology Society, Chinese Medical Association [3] Wang Y, Liu W, et al. Body Composition Measurement Improved Performance of GLIM Criteria in Diagnosing Malnutrition Compared to PG-SGA in Ambulatory Cancer Patients: A Prospective Cross-Sectional Study. *Nutrients*. 2021 Aug 10;13(8):2744. [4] Xu Z, Liu W, et al. miR-378a-3p sensitizes ovarian cancer cells to cisplatin through targeting MAPK1/GRB2. *Biomedicine & Pharmacotherapy*. 107 (2018) 1410-1417. [5] Hu WX, Liu W, et al. Periostin Contributes to Cisplatin Resistance in Human Non-small Cell Lung Cancer A549 Cells via Activation of Stat3 and Akt and Upregulation of Survivin. *Cellular Physiology and Biochemistry*, 2016, 38(3):1199-1208.